Gemfibrozil |
Lopid |
Gemfibrozil Systematic (IUPAC) name 5-(2,5-dimethylphenoxy)-2,2-dimethyl-pentanoic acid Identifiers CAS number 25812-30-0 ATC code C10AB04 PubChem 3463 DrugBank APRD00293 Chemical data Formula C15H22O3 Mol. weight 250.333 g/mol Pharmacokinetic data Bioavailability Close to 100% Protein binding 95% Metabolism Hepatic (CYP3A4) Half life 1.5 hours Excretion Renal 94% Feces 6% Therapeutic considerations Pregnancy cat. Category C Legal status By Pre ...
Wikipedia - [full article]
Gemfibrozil Clinical Trials
- Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides
ClinicalTrials.gov Identifier: NCT00108511 - Completed
Hypertriglyceridemia
- Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil
ClinicalTrials.gov Identifier: NCT00474201 - Recruiting
HIV Infections; Cholesterol
- Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil
ClinicalTrials.gov Identifier: NCT00566865 - Recruiting
Type 2 Diabetes Mellitus
- Endothelial Dysfunction as a Risk Factor in HIV Study
ClinicalTrials.gov Identifier: NCT00039663 - Completed
HIV Infections
- Harvard Atherosclerosis Reversibility Project (HARP)
ClinicalTrials.gov Identifier: NCT00000461 - Completed
Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia

Not Signed In -


